These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23337054)

  • 1. Protective mechanisms against oxidative stress and angiopathy in young patients with diabetes type 1 (DM1).
    Koutroumani N; Partsalaki I; Lamari F; Dettoraki A; Gil AP; Karvela A; Kostopoulou E; Spiliotis BE
    J Pediatr Endocrinol Metab; 2013; 26(3-4):309-17. PubMed ID: 23337054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
    Dettoraki A; Gil AP; Spiliotis BE
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):895-904. PubMed ID: 20020577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of pioglitazone and glimepiride on plasma soluble RAGE and RAGE expression in peripheral mononuclear cells in type 2 diabetes: randomized controlled trial (PioRAGE).
    Koyama H; Tanaka S; Monden M; Shoji T; Morioka T; Fukumoto S; Mori K; Emoto M; Shoji T; Fukui M; Fujii H; Nishizawa Y; Inaba M
    Atherosclerosis; 2014 Jun; 234(2):329-34. PubMed ID: 24727234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
    Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
    Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Yamasaki Y
    Diab Vasc Dis Res; 2008 Sep; 5(3):190-7. PubMed ID: 18777492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.
    Gao X; Zhang H; Schmidt AM; Zhang C
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H491-8. PubMed ID: 18539754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
    Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
    Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
    Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
    Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble RAGE in type 2 diabetes: association with oxidative stress.
    Devangelio E; Santilli F; Formoso G; Ferroni P; Bucciarelli L; Michetti N; Clissa C; Ciabattoni G; Consoli A; Davì G
    Free Radic Biol Med; 2007 Aug; 43(4):511-8. PubMed ID: 17640561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications.
    Chawla D; Bansal S; Banerjee BD; Madhu SV; Kalra OP; Tripathi AK
    Microvasc Res; 2014 Sep; 95():1-6. PubMed ID: 24984291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
    Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
    Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
    Abdel-Azeez HA; El-Okely AM
    Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
    Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
    Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP; Machado-Lima A; Monteiro MB; Admoni SN; Perez RV; Machado CG; Shimizu MH; Cavaleiro AM; Thieme K; Queiroz MS; Machado UF; Giannella-Neto D; Passarelli M; Corrêa-Giannella ML
    Diab Vasc Dis Res; 2018 Jan; 15(1):81-89. PubMed ID: 29027826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients.
    Huang M; Que Y; Shen X
    J Diabetes Complications; 2015 Apr; 29(3):422-6. PubMed ID: 25659638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.